PLCB2

PLCB2 encodes phospholipase C-β2, a G protein-coupled receptor effector that hydrolyzes membrane phosphoinositides to generate the second messengers diacylglycerol (DAG) and IP3, coupling GPCR activation to downstream signaling across immune, sensory, and proliferative contexts (PMID:10101223, PMID:41365690). In neutrophils, IL-8 receptor engagement signals through pertussis toxin-sensitive Gi proteins to activate PLC-β2, whose products mobilize intracellular Ca2+ and activate PKC (PMID:10101223); its DAG output drives the RasGEF RasGRP4 to stimulate Ras and class I PI3Kγ, thereby controlling PIP3 accumulation, PKB activation, chemokinesis, and reactive oxygen species formation (PMID:22728827). In gustatory transduction, PLC-β2 is the essential effector of canonical TAS1R-mediated sweet taste, and its genetic loss abolishes this pathway while sparing a separate noncanonical sugar-sensing route (PMID:41365690). PLCB2 expression in megakaryocytes and platelets is directly driven by NF-κB through a p65 binding site in its promoter (PMID:27465150). In cancer settings, PLCB2 supports proliferation, migration, invasion, and EMT, acting upstream of PI3K/AKT signaling, as a PI3K activator rescues the defects caused by PLCB2 knockdown (PMID:40002717, PMID:31746389).

1. 1996 Low

   Before functional characterization, the genomic position of Plcb2 needed definition to enable linkage and comparative studies, establishing conserved synteny between mouse and human loci.

   Evidence RFLP analysis in genetic crosses and human × rodent somatic cell hybrid mapping

   PMID:8672127

   Open questions at the time

   • Chromosomal mapping only — no functional or mechanistic data
   • Does not address protein activity or signaling role
2. 1999 Medium

   Established how chemokine receptors engage PLC-β2, showing that IL-8 receptor signaling routes through Gi proteins to activate PLC-β2 and generate DAG and IP3 in neutrophils.

   Evidence Pertussis toxin epistasis and biochemical PLC/IP3/Ca2+/PKC assays in neutrophils (review summary of experimental studies)

   PMID:10101223

   Open questions at the time

   • Summarized in review rather than primary single-study data
   • Does not distinguish PLC-β2 from co-expressed PLC isoforms
3. 2001 Medium

   Tested whether PLC-β2 enzymatic activity is directly sufficient to drive downstream channel gating, showing that its PIP2-hydrolyzing activity activates TrpL channels in excised patches.

   Evidence Patch clamp electrophysiology on excised inside-out patches with direct cytoplasmic application of mammalian PLC-β2; fura-2 Ca2+ assays; U73122 blockade

   PMID:11136854

   Open questions at the time

   • Heterologous Drosophila channel readout, not a mammalian effector
   • No mutagenesis or structural validation of the catalytic requirement
4. 2012 High

   Defined the signaling consequence of PLC-β2 DAG production downstream of GPCRs, placing PLC-β2/β3 upstream of Ras and PI3Kγ via RasGRP4 in neutrophil chemotaxis.

   Evidence Genetic epistasis with RasGRP4 knockout and Ras-insensitive PI3Kγ knock-in mice; PIP3, PKB, chemokinesis, and ROS readouts

   PMID:22728827

   Open questions at the time

   • Does not isolate PLC-β2 from PLC-β3 contribution
   • Structural basis of DAG-to-RasGRP4 coupling not addressed
5. 2016 High

   Identified the transcriptional control of PLCB2, showing NF-κB p65 directly binds the promoter and sets PLC-β2 levels in megakaryocytes and platelets.

   Evidence EMSA, luciferase reporter assays of PLCB2 promoter constructs, p65 siRNA knockdown and overexpression, and protein correlation in primary platelets

   PMID:27465150

   Open questions at the time

   • Functional consequence for platelet physiology not directly tested
   • Conducted in a single lab
6. 2019 Medium

   Linked PLCB2 to tumor cell survival, showing that its knockdown suppresses melanoma viability and promotes apoptosis with reduced Ras/Raf/MAPK signaling.

   Evidence siRNA knockdown, colony formation, apoptosis flow cytometry, CCK-8 viability, and Ras/Raf/MAPK pathway readouts in melanoma cells

   PMID:31746389

   Open questions at the time

   • Single approach, single lab
   • Causal direction within Ras/Raf/MAPK not mechanistically dissected
7. 2024 Low

   Associated PLCB2 with epithelial homeostasis, with elevated PLCB2 expression coinciding with reduced pyroptosis via NLRP3/caspase-1/GSDMD-N in a colitis model.

   Evidence DSS-induced UC mouse model and colonic epithelial cell lines; qRT-PCR, CCK-8, ELISA, Western blotting after Astragalus extract treatment

   PMID:38992398

   Open questions at the time

   • PLCB2 modulated indirectly via plant extract, not by direct genetic manipulation
   • Causal role of PLCB2 in pyroptosis not established
8. 2025 Medium

   Placed PLCB2 upstream of PI3K/AKT in carcinoma invasion, with PI3K activation rescuing the migration, invasion, and EMT defects of PLCB2 knockdown.

   Evidence siRNA knockdown, transcriptome sequencing, and 740Y-P PI3K activator rescue with proliferation/invasion/migration assays in RCC cells

   PMID:40002717

   Open questions at the time

   • Mechanism connecting PLC-β2 catalysis to PI3K/AKT not defined
   • Single lab, cell-line-only system
9. 2026 High

   Established PLCB2 as the obligate effector of canonical TAS1R sweet taste transduction while revealing an independent noncanonical sugar pathway it does not control.

   Evidence In vivo Ca2+ imaging of geniculate ganglion afferents in Plcb2 knockout mice; ionic/pharmacological manipulation and glucose vs fructose comparison

   PMID:41365690

   Open questions at the time

   • Molecular identity of the noncanonical pathway unresolved
   • Does not address PLC-β2's role in non-sweet (T2R) taste modalities

• How PLC-β2 catalytic output is mechanistically channeled to divergent downstream pathways (RasGRP4/Ras versus PI3K/AKT) across cell types, and the functional significance of its proteolytic processing, remain unresolved.
• No structural model linking catalysis to specific effector recruitment
• Functional consequence of corneal-induced PLCB2 cleavage uncharacterized
• Relative contributions of PLC-β2 versus other PLC-β isoforms not resolved